Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Novartis
NVS
$290B
| $2.17M | ﹤0.01% |
28,048
+15,139
| +117% | +$1.12M |
|
|
RAVN
2752
DELISTED
Raven Industries Inc
RAVN
| $2.17M | ﹤0.01% |
47,364
+20,985
| +80% | +$893K |
|
|
CRC
2753
PUT
DELISTED
California Resources Corporation
CRC
| $2.16M | ﹤0.01% |
44,500
+8,000
| +22% | +$308K |
|
2754
CALL
Edgewell Personal Care
EPC
$1.32B
| $2.16M | ﹤0.01% |
46,700
+20,400
| +78% | +$1.08M |
|
2755
UMB Financial
UMBF
$11.4B
| $2.16M | ﹤0.01% |
30,441
+17,172
| +129% | +$1.29M |
|
|
RDS.A
2756
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $2.16M | ﹤0.01% |
31,615
+26,519
| +520% | +$1.77M |
|
|
WAGE
2757
DELISTED
WageWorks, Inc.
WAGE
| $2.15M | ﹤0.01% |
50,398
+26,757
| +113% | +$1.35M |
|
|
MDRX
2758
DELISTED
Veradigm Inc. Common Stock
MDRX
| $2.15M | ﹤0.01% |
150,974
+59,909
| +66% | +$814K |
|
2759
Halozyme
HALO
$11.6B
| $2.15M | ﹤0.01% |
118,211
+98,175
| +490% | +$1.72M |
|
|
CORE
2760
DELISTED
Core Mark Holding Co., Inc.
CORE
| $2.15M | ﹤0.01% |
63,217
+46,371
| +275% | +$1.39M |
|
|
HSII
2761
DELISTED
Heidrick & Struggles
HSII
| $2.14M | ﹤0.01% |
63,205
+46,443
| +277% | +$1.81M |
|
|
P
2762
Everpure Inc
P
$37B
| $2.14M | ﹤0.01% |
82,461
+56,508
| +218% | +$1.4M |
|
2763
CALL
Tyson Foods
TSN
$19.6B
| $2.14M | ﹤0.01% |
35,900
+9,500
| +36% | +$594K |
|
2764
US Physical Therapy
USPH
$1.22B
| $2.14M | ﹤0.01% |
18,033
+12,196
| +209% | +$1.38M |
|
|
ATHN
2765
PUT
DELISTED
Athenahealth, Inc.
ATHN
| $2.14M | ﹤0.01% |
16,000
-371,500
| -96% | -$55.7M |
|
|
CHL
2766
CALL
DELISTED
China Mobile Limited
CHL
| $2.14M | ﹤0.01% |
43,700
+25,800
| +144% | +$1.19M |
|
2767
Innospec
IOSP
$2.29B
| $2.13M | ﹤0.01% |
27,831
+16,532
| +146% | +$1.29M |
|
2768
Genpact
G
$5.7B
| $2.13M | ﹤0.01% |
69,698
-140,799
| -67% | -$4.28M |
|
2769
National Beverage
FIZZ
$2.9B
| $2.13M | ﹤0.01% |
36,544
+31,490
| +623% | +$1.77M |
|
2770
PUT
Honeywell
HON
$74.6B
| $2.13M | ﹤0.01% |
14,170
-7,970
| -36% | -$1.13M |
|
2771
PUT
Welltower
WELL
$166B
| $2.13M | ﹤0.01% |
33,100
-4,700
| -12% | -$304K |
|
2772
Commault Systems
CVLT
$5.87B
| $2.12M | ﹤0.01% |
30,279
+19,942
| +193% | +$1.35M |
|
2773
KLX Energy Services
KLXE
$35.1M
| $2.12M | ﹤0.01% |
+13,244
| New | +$1.99M |
|
|
BRSL
2774
CALL
Brightstar Lottery PLC
BRSL
$2.08B
| $2.12M | ﹤0.01% |
107,300
+30,300
| +39% | +$660K |
|
2775
PUT
NextEra Energy
NEE
$179B
| $2.11M | ﹤0.01% |
50,400
+16,000
| +47% | +$681K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.